Proceedings: Therapy of the lymphostatic encephalopathy in rats.
D000470:Alkaloids / Q000627:therapeutic use; D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use; D001927:Brain Diseases / Q000188:drug therapy*; D002482:Cellulose / Q000627:therapeutic use; D003374:Coumarins / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D008206:Lymphatic Diseases / Q000188:drug therapy; D011725:Pyridines / Q000627:therapeutic use; D051381:Rats; D014202:Tremor / Q000139:chemically induced / Q000188:drug therapy
D000470:Alkaloids; D003374:Coumarins; D007211:Indoles; D011725:Pyridines; D002482:Cellulose; D007611:Aprotinin; D007213:Indomethacin